Cargando…

CXCR4 Inhibition Counteracts Immunosuppressive Properties of Metastatic NSCLC Stem Cells

Cancer stem cells (CSCs) are functionally defined as the cell subset with greater potential to initiate and propagate tumors. Within the heterogeneous population of lung CSCs, we previously identified highly disseminating CD133+CXCR4+ cells able to initiate distant metastasis (metastasis initiating...

Descripción completa

Detalles Bibliográficos
Autores principales: Fortunato, Orazio, Belisario, Dimas Carolina, Compagno, Mara, Giovinazzo, Francesca, Bracci, Cristiano, Pastorino, Ugo, Horenstein, Alberto, Malavasi, Fabio, Ferracini, Riccardo, Scala, Stefania, Sozzi, Gabriella, Roz, Luca, Roato, Ilaria, Bertolini, Giulia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566588/
https://www.ncbi.nlm.nih.gov/pubmed/33123122
http://dx.doi.org/10.3389/fimmu.2020.02168
_version_ 1783596158965252096
author Fortunato, Orazio
Belisario, Dimas Carolina
Compagno, Mara
Giovinazzo, Francesca
Bracci, Cristiano
Pastorino, Ugo
Horenstein, Alberto
Malavasi, Fabio
Ferracini, Riccardo
Scala, Stefania
Sozzi, Gabriella
Roz, Luca
Roato, Ilaria
Bertolini, Giulia
author_facet Fortunato, Orazio
Belisario, Dimas Carolina
Compagno, Mara
Giovinazzo, Francesca
Bracci, Cristiano
Pastorino, Ugo
Horenstein, Alberto
Malavasi, Fabio
Ferracini, Riccardo
Scala, Stefania
Sozzi, Gabriella
Roz, Luca
Roato, Ilaria
Bertolini, Giulia
author_sort Fortunato, Orazio
collection PubMed
description Cancer stem cells (CSCs) are functionally defined as the cell subset with greater potential to initiate and propagate tumors. Within the heterogeneous population of lung CSCs, we previously identified highly disseminating CD133+CXCR4+ cells able to initiate distant metastasis (metastasis initiating cells-MICs) and to resist conventional chemotherapy. The establishment of an immunosuppressive microenvironment by tumor cells is crucial to sustain and foster metastasis formation, and CSCs deeply interfere with immune responses against tumors. How lung MICs can elude and educate immune cells surveillance to efficiently complete the metastasis cascade is, however, currently unknown. We show here in primary tumors from non-small cell lung cancer (NSCLC) patients that MICs express higher levels of immunoregulatory molecules compared to tumor bulk, namely PD-L1 and CD73, an ectoenzyme that catalyzes the production of immunosuppressive adenosine, suggesting an enhanced ability of MICs to escape immune responses. To investigate in vitro the immunosuppressive ability of MICs, we derived lung spheroids from cultures of adherent lung cancer cell lines, showing enrichment in CD133+CXCR4+MICs, and increased expression of CD73 and CD38, an enzyme that also concurs in adenosine production. MICs-enriched spheroids release high levels of adenosine and express the immunosuppressive cytokine IL-10, undetectable in an adherent cell counterpart. To prevent dissemination of MICs, we tested peptide R, a novel CXCR4 inhibitor that effectively controls in vitro lung tumor cell migration/invasion. Notably, we observed a decreased expression of CD73, CD38, and IL-10 following CXCR4 inhibition. We also functionally proved that conditioned medium from MICs-enriched spheroids compared to adherent cells has an enhanced ability to suppress CD8+ T cell activity, increase Treg population, and induce the polarization of tumor-associated macrophages (TAMs), which participate in suppression of T cells. Treatment of spheroids with anti-CXCR4 rescued T cell cytotoxic activity and prevented TAM polarization, likely by causing the decrease of adenosine and IL-10 production. Overall, we provide evidence that the subset of lung MICs shows high potential to escape immune control and that inhibition of CXCR4 can impair both MICs dissemination and their immunosuppressive activity, therefore potentially providing a novel therapeutic target in combination therapies to improve efficacy of NSCLC treatment.
format Online
Article
Text
id pubmed-7566588
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-75665882020-10-28 CXCR4 Inhibition Counteracts Immunosuppressive Properties of Metastatic NSCLC Stem Cells Fortunato, Orazio Belisario, Dimas Carolina Compagno, Mara Giovinazzo, Francesca Bracci, Cristiano Pastorino, Ugo Horenstein, Alberto Malavasi, Fabio Ferracini, Riccardo Scala, Stefania Sozzi, Gabriella Roz, Luca Roato, Ilaria Bertolini, Giulia Front Immunol Immunology Cancer stem cells (CSCs) are functionally defined as the cell subset with greater potential to initiate and propagate tumors. Within the heterogeneous population of lung CSCs, we previously identified highly disseminating CD133+CXCR4+ cells able to initiate distant metastasis (metastasis initiating cells-MICs) and to resist conventional chemotherapy. The establishment of an immunosuppressive microenvironment by tumor cells is crucial to sustain and foster metastasis formation, and CSCs deeply interfere with immune responses against tumors. How lung MICs can elude and educate immune cells surveillance to efficiently complete the metastasis cascade is, however, currently unknown. We show here in primary tumors from non-small cell lung cancer (NSCLC) patients that MICs express higher levels of immunoregulatory molecules compared to tumor bulk, namely PD-L1 and CD73, an ectoenzyme that catalyzes the production of immunosuppressive adenosine, suggesting an enhanced ability of MICs to escape immune responses. To investigate in vitro the immunosuppressive ability of MICs, we derived lung spheroids from cultures of adherent lung cancer cell lines, showing enrichment in CD133+CXCR4+MICs, and increased expression of CD73 and CD38, an enzyme that also concurs in adenosine production. MICs-enriched spheroids release high levels of adenosine and express the immunosuppressive cytokine IL-10, undetectable in an adherent cell counterpart. To prevent dissemination of MICs, we tested peptide R, a novel CXCR4 inhibitor that effectively controls in vitro lung tumor cell migration/invasion. Notably, we observed a decreased expression of CD73, CD38, and IL-10 following CXCR4 inhibition. We also functionally proved that conditioned medium from MICs-enriched spheroids compared to adherent cells has an enhanced ability to suppress CD8+ T cell activity, increase Treg population, and induce the polarization of tumor-associated macrophages (TAMs), which participate in suppression of T cells. Treatment of spheroids with anti-CXCR4 rescued T cell cytotoxic activity and prevented TAM polarization, likely by causing the decrease of adenosine and IL-10 production. Overall, we provide evidence that the subset of lung MICs shows high potential to escape immune control and that inhibition of CXCR4 can impair both MICs dissemination and their immunosuppressive activity, therefore potentially providing a novel therapeutic target in combination therapies to improve efficacy of NSCLC treatment. Frontiers Media S.A. 2020-10-02 /pmc/articles/PMC7566588/ /pubmed/33123122 http://dx.doi.org/10.3389/fimmu.2020.02168 Text en Copyright © 2020 Fortunato, Belisario, Compagno, Giovinazzo, Bracci, Pastorino, Horenstein, Malavasi, Ferracini, Scala, Sozzi, Roz, Roato and Bertolini http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Fortunato, Orazio
Belisario, Dimas Carolina
Compagno, Mara
Giovinazzo, Francesca
Bracci, Cristiano
Pastorino, Ugo
Horenstein, Alberto
Malavasi, Fabio
Ferracini, Riccardo
Scala, Stefania
Sozzi, Gabriella
Roz, Luca
Roato, Ilaria
Bertolini, Giulia
CXCR4 Inhibition Counteracts Immunosuppressive Properties of Metastatic NSCLC Stem Cells
title CXCR4 Inhibition Counteracts Immunosuppressive Properties of Metastatic NSCLC Stem Cells
title_full CXCR4 Inhibition Counteracts Immunosuppressive Properties of Metastatic NSCLC Stem Cells
title_fullStr CXCR4 Inhibition Counteracts Immunosuppressive Properties of Metastatic NSCLC Stem Cells
title_full_unstemmed CXCR4 Inhibition Counteracts Immunosuppressive Properties of Metastatic NSCLC Stem Cells
title_short CXCR4 Inhibition Counteracts Immunosuppressive Properties of Metastatic NSCLC Stem Cells
title_sort cxcr4 inhibition counteracts immunosuppressive properties of metastatic nsclc stem cells
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566588/
https://www.ncbi.nlm.nih.gov/pubmed/33123122
http://dx.doi.org/10.3389/fimmu.2020.02168
work_keys_str_mv AT fortunatoorazio cxcr4inhibitioncounteractsimmunosuppressivepropertiesofmetastaticnsclcstemcells
AT belisariodimascarolina cxcr4inhibitioncounteractsimmunosuppressivepropertiesofmetastaticnsclcstemcells
AT compagnomara cxcr4inhibitioncounteractsimmunosuppressivepropertiesofmetastaticnsclcstemcells
AT giovinazzofrancesca cxcr4inhibitioncounteractsimmunosuppressivepropertiesofmetastaticnsclcstemcells
AT braccicristiano cxcr4inhibitioncounteractsimmunosuppressivepropertiesofmetastaticnsclcstemcells
AT pastorinougo cxcr4inhibitioncounteractsimmunosuppressivepropertiesofmetastaticnsclcstemcells
AT horensteinalberto cxcr4inhibitioncounteractsimmunosuppressivepropertiesofmetastaticnsclcstemcells
AT malavasifabio cxcr4inhibitioncounteractsimmunosuppressivepropertiesofmetastaticnsclcstemcells
AT ferraciniriccardo cxcr4inhibitioncounteractsimmunosuppressivepropertiesofmetastaticnsclcstemcells
AT scalastefania cxcr4inhibitioncounteractsimmunosuppressivepropertiesofmetastaticnsclcstemcells
AT sozzigabriella cxcr4inhibitioncounteractsimmunosuppressivepropertiesofmetastaticnsclcstemcells
AT rozluca cxcr4inhibitioncounteractsimmunosuppressivepropertiesofmetastaticnsclcstemcells
AT roatoilaria cxcr4inhibitioncounteractsimmunosuppressivepropertiesofmetastaticnsclcstemcells
AT bertolinigiulia cxcr4inhibitioncounteractsimmunosuppressivepropertiesofmetastaticnsclcstemcells